Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Different volatility measures reveal different risk facets of stock indices. This primer clarifies what each metric means for decisions.
23,218 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Analysts break down the president's State of the Union remarks on growth, jobs, and health costs. Fact-checking outli...
As March 2026 unfolds, investors are parsing the streaming slate for signals on subscriber growth, monetization, and ...
JPMorgan’s Jamie Dimon reveals a simple, enduring rule that shaped his ascent from a young Harvard MBA assistant to t...
Tech stocks are delivering a mixed performance as AI-driven catalysts intersect with macro signals. The live nasdaq c...
Ford faced a massive quarterly loss tied to EV charges, while Winnebago posted a surprise profit swing on premium mot...
Non-US markets rebound as the dollar weakens, prompting retirees to seek ESG-friendly exposure that also delivers div...
A mixed-bag forecast brings heat, rain, snow, and Arctic chills across the United States, with notable implications f...
A look at how a $1,000 stake in McDonald’s versus Starbucks would have evolved over the past decade, with today’s mar...
Freddie Mac data show mortgage rates climbed to their highest level in almost four months, pushing the 30-year loan t...
Cursor, valued near $29 billion, stands at the center of a fast-moving AI coding boom. The company faces intense grow...
Two of the nation’s biggest brokerages are expanding teen access to the markets with unsupervised accounts for 13-yea...